Drug Trial Radar · NCT06137157
Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome
Last checked: Nov 20, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6
Actual
Start
Jun 16, 2024
Primary completion
Jul 7, 2026
Study completion Jul 7, 2026
Sponsor
- Lead sponsor
- Azitra Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 18, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objectives of this clinical trial are to evaluate the safety and tolerability of topically applied ATR12-351, to understand what the body does to ATR12-351, and to observe treatment benefits of the drug in approximately 12 adult patients with Netherton Syndrome (NS). ATR12-351 will be applied to skin lesions on one side of the body, while the vehicle control will be applied to similar lesion on the other side of the body twice daily for 2 weeks.
Conditions
- Netherton Syndrome
Interventions
ATR12-351Drug
Topical ointment containing ATR12-351, a LEKTI-secreting strain of S. epidermidis
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventsTime frame: 84 days
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
Yale University
New Haven, Connecticut
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.